Sponsors

Lead Sponsor

Shanghai University of Traditional Chinese Medicine

Metastasis is the leading cause of death in patients with lung cancer, and circulating tumor cells play a key role in the process of distant metastasis.In recent years, research results have shown that CTCs may become a emerging marker and new target in the treatment of lung cancer. The investigators' study will elaborate the clinical significance of CTCs intervented by TCM in lung cancer from the diagnosis and clinical staging,metastasis and recurrence, individual treatment and prognosis and so on, in order to provide a new direction for the treatment of lung cancer.

Related studies

RECRUITINGPhase 2

Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer

NCT05765877 · Non-Small Cell Lung Cancer(NSCLC)

Not Yet Recruiting

A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude Areas

NCT06757114 · Non-small Cell Lung Cancer(NSCLC)

COMPLETEDPhase 1/2

A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib

NCT01712217 · Non-small Cell Lung Cancer(NSCLC)

COMPLETEDPhase 3

To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-line Treatment of Advanced or Relapsed NSCLC

NCT05169801 · Non-small Cell Lung Cancer(NSCLC)

UNKNOWNPhase 3

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

NCT02667743 · Non-Small Cell Lung Cancer(NSCLC)

the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs

What this study is about

Clareo turns complex medical information into clear understanding you can use.